Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

FDA Approval Summary: Vemurafenib for the Treatment of Patients with Erdheim-Chester Disease with the BRAFV600 Mutation

Patricia A. Oneal,Virginia Kwitkowski,Lola Luo,Yuan Li Shen,Sriram Subramaniam,Stacy Shord,Kirsten B. Goldberg,Amy E. McKee,Edvardas Kaminskas,Ann Farrell,Richard Pazdu

The Oncologist（2018）

Cited 52|Views21
No score
Key words
Non-Langerhans cell histocytosis,Vemurafenib,Zelboraf,Histiocytosis,BRAFV600 mutations
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined